摘要
基质金属蛋白酶(MMP)是一组锌依赖性金属内肽酶,负责细胞外基质成分的降解,修复和重塑。 MMP在维持正常的生理功能和预防疾病(例如癌症和心血管疾病)中起着重要作用。源自植物的天然产物已经用作传统药物已有数百年历史了。它的活性化合物(例如儿茶素,白藜芦醇和槲皮素)作为MMPs抑制剂发挥着重要作用,从而为它们在许多领域的应用打开了新的见解,例如制药,化妆品和食品工业。这篇综述总结了具有MMP调节活性的植物来源的天然产物的当前知识。大多数审查的植物来源的产品表现出对MMPs的抑制活性。在MMP中,对MMP-2和MMP-9的研究最多。 MMPs的表达通过相应的信号通路(例如MAPK,NF-κB和PI3激酶通路)被抑制,这有助于减少癌细胞行为(例如增殖和迁移)。大多数研究都采用了体外模型,但仅进行了有限的动物研究和临床试验。即使植物来源的产品在调节MMP方面显示出可喜的成果,但仍需要更多的体内研究和临床试验来支持其未来的治疗应用。
关键词: 抗癌,细胞外基质,基质金属蛋白酶,MMP,天然产物,植物,肿瘤。
图形摘要
Current Cancer Drug Targets
Title:Modulation of Matrix Metalloproteinases by Plant-derived Products
Volume: 21 Issue: 2
关键词: 抗癌,细胞外基质,基质金属蛋白酶,MMP,天然产物,植物,肿瘤。
摘要: Matrix metalloproteinases (MMPs) are a group of zinc-dependent metalloendopeptidases that are responsible for the degradation, repair, and remodeling of extracellular matrix components. MMPs play an important role in maintaining a normal physiological function and preventing diseases, such as cancer and cardiovascular diseases. Natural products derived from plants have been used as traditional medicine for centuries. Its active compounds, such as catechin, resveratrol and quercetin, are suggested to play an important role as MMPs inhibitors, thereby opening new insights into their applications in many fields, such as pharmaceutical, cosmetic, and food industries. This review summarises the current knowledge of plant-derived natural products with MMP-modulating activities. Most of the reviewed plant-derived products exhibit an inhibitory activity on MMPs. Amongst MMPs, MMP-2 and MMP-9 are the most studied. The expression of MMPs is inhibited through respective signaling pathways, such as MAPK, NF-κB and PI3 kinase pathways, which contribute to the reduction in cancer cell behaviors, such as proliferation and migration. Most studies have employed in vitro models, but a limited number of animal studies and clinical trials have been conducted. Even though plant-derived products show promising results in modulating MMPs, more in vivo studies and clinical trials are needed to support their therapeutic applications in the future.
Export Options
About this article
Cite this article as:
Modulation of Matrix Metalloproteinases by Plant-derived Products, Current Cancer Drug Targets 2021; 21 (2) . https://dx.doi.org/10.2174/1568009620666201120144838
DOI https://dx.doi.org/10.2174/1568009620666201120144838 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer
Current Medicinal Chemistry Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Anti-Cancer Agents in Medicinal Chemistry Some Wild-Growing Plant Species from Serbia and Montenegro as the Potential Sources of Drugs
Current Pharmaceutical Design Design and Application of Magnetic-Based Theranostic Nanoparticle Systems
Recent Patents on Biomedical Engineering (Discontinued) Kinase Inhibitors with Redox and Anti-inflammatory Activities
Current Topics in Medicinal Chemistry Targeting Angiogenesis in Head and Neck Cancer
Current Cancer Drug Targets Differentiation of High-grade Gliomas from Brain Metastases Using Tissue Similarity Maps (TSMs) Based Relative Cerebral Blood Volume Values
Current Medical Imaging A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors
Central Nervous System Agents in Medicinal Chemistry The Potency of Refined Mouse Models: Implications for Clinical Trials
Current Cancer Therapy Reviews Protein Targeting Constructs in Alpha Therapy
Current Radiopharmaceuticals Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Current Pharmaceutical Design Dual Targeting of Autophagy and NF-κB Pathway by PPARγ Contributes to the Inhibitory Effect of Demethoxycurcumin on NLRP3 Inflammasome Priming
Current Molecular Pharmacology Applications of Polymeric Nanocapsules in Field of Drug Delivery Systems
Current Drug Discovery Technologies Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit
Current Neurovascular Research The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors
Current Medicinal Chemistry The History of the HSV Amplicon: From Naturally Occurring Defective Genomes to Engineered Amplicon Vectors
Current Gene Therapy Regulation of Hypoxia-inducible Factor-1α and Vascular Endothelial Growth Factor Signaling by Plant Flavonoids
Mini-Reviews in Medicinal Chemistry The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Anticancer Effects of Ginsenoside Rh2: A Systematic Review
Current Molecular Pharmacology Molecular Mechanisms Regulating mRNA Stability: Physiological and Pathological Significance
Current Genomics